Insider Trading November 10, 2026 10:31 PM

IBEX Director McGinnis Offloads $126,207 in Shares as Stock Hovers Near 52-Week High

The sale of 2,500 shares comes as IBEX trades at $52.23, close to its 52-week peak, following a 61% six-month rally.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
IBEX

Patrick McGinnis, a director at IBEX Ltd, sold 2,500 common shares on November 10, 2026, for a total of $126,207, with prices between $50.15 and $50.78. After the sale, McGinnis directly holds 4,585 shares. The stock has climbed 61% over the past six months and now trades at $52.23, near its 52-week high of $52.29. IBEX appears overvalued at current levels, according to an analysis, and carries a P/E ratio of 15.5 with a market cap of $696 million. The company recently reported stronger-than-expected fiscal first-quarter results, with adjusted earnings of $1.10 per share on record revenue of $175.2 million, and raised its full-year outlook.

IBEX Director McGinnis Offloads $126,207 in Shares as Stock Hovers Near 52-Week High
IBEX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Patrick McGinnis sold 2,500 IBEX shares for $126,207, reducing his direct holdings to 4,585 shares.
  • IBEX stock has gained 61% over six months and trades near its 52-week high, with a P/E of 15.5 and a market cap of $696 million.
  • The company recently beat fiscal first-quarter estimates with adjusted EPS of $1.10 and record revenue of $175.2 million, and raised its full-year outlook.

IBEX Ltd (NASDAQ:IBEX) director Patrick McGinnis sold 2,500 common shares of the company on November 10, 2026, according to a recent disclosure. The transactions were executed at prices ranging from $50.15 to $50.78 per share, amounting to a total of $126,207.

Following the sale, McGinnis directly holds 4,585 common shares of IBEX. The transaction comes as the stock has surged 61% over the past six months and currently trades at $52.23, just below its 52-week high of $52.29.

According to an analysis, IBEX appears overvalued at current levels, placing it among stocks on the most overvalued list. The company trades at a P/E ratio of 15.5 with a market cap of $696 million.

In other recent news, IBEX reported stronger-than-expected fiscal first-quarter results. The company achieved adjusted earnings of $1.10 per share, surpassing the forecast of $0.93. Revenue for the quarter reached a record $175.2 million, exceeding the estimated $168.93 million. This represents a 16% increase from the previous year. Additionally, IBEX raised its full-year outlook, signaling positive expectations for the future. These developments highlight the company’s robust performance and growth trajectory.

Risks

  • The stock appears overvalued at current levels, which could lead to a price correction.
  • Insider selling may be perceived negatively by investors, potentially affecting market sentiment.
  • The company operates in a competitive industry, and future performance depends on maintaining growth momentum.

More from Insider Trading

Prudential CEO Sullivan Offloads $430,000 in Shares Following Option Exercises Nov 10, 2026 Ouster Director Skaggs Offloads $170,000 in Stock Under Pre-Set Trading Plan Nov 10, 2026 IBEX Legal Chief Offloads Shares Near 52-Week High as Stock Surges Nov 10, 2026 Microsoft CFO Amy Hood Offloads $3.98 Million in Stock Under Prearranged Plan Nov 10, 2026 Reddit Director Gale Porter Offloads $384,000 in RDDT Shares as Stock Slumps Nov 10, 2026